Biochar supercharges a solar-powered catalyst that destroys antibiotic pollution in water

Antibiotics are saving lives and poisoning water at the same time. Pharmaceutical compounds that survive the human body and wastewater treatment end up in rivers, lakes, and groundwater, where they persist long enough to disrupt microbial communities and - most worrying - accelerate the spread of antibiotic resistance. Conventional water treatment plants were not designed to remove these molecules, and adding the necessary technology is expensive.

A study published in the journal Biochar offers a different approach: let the sun do the work.

Three materials, one composite

The research team designed a ternary photocatalyst - a material that uses light energy to drive chemical reactions that break down pollutants. The composite combines three components: biochar (a carbon-rich material produced from biomass), titanium dioxide (TiO2, a widely studied semiconductor photocatalyst), and graphitic carbon nitride (g-C3N4, another semiconductor active under visible light).

Each component brings something the others lack. TiO2 is a proven photocatalyst but performs poorly under visible light and suffers from rapid recombination of the electrons and holes it generates - essentially short-circuiting its own catalytic process. g-C3N4 extends the light absorption range into the visible spectrum. And biochar acts as an electron reservoir, catching electrons before they can recombine and funneling them toward pollutant degradation.

98% degradation in one hour

The optimized composite, designated MBC-500, was tested against sulfadiazine, a sulfonamide antibiotic widely used in both human and veterinary medicine and frequently detected in aquatic environments.

Under simulated sunlight, MBC-500 removed more than 98% of sulfadiazine from water within one hour. That degradation rate was more than three times greater than either pure TiO2 or g-C3N4 alone. The biochar component was responsible for much of the improvement: it dramatically increased the material's surface area, created a more complex porous structure with abundant active sites for adsorption and catalytic reactions, and prevented the electron-hole recombination that limits conventional photocatalysts.

How the electrons move

The researchers used advanced computational simulations to understand what happens at the electronic level. Biochar modifies the electronic structure of the TiO2/g-C3N4 heterojunction - the interface where the two semiconductors meet - enabling faster electron transfer and more efficient generation of reactive oxygen species.

Those reactive species - superoxide radicals, hydroxyl radicals, and photogenerated holes - are the actual agents of destruction. They attack the antibiotic molecules, gradually transforming sulfadiazine into smaller, less harmful compounds before ultimately mineralizing them into carbon dioxide, water, and inorganic ions.

The team proposed detailed degradation pathways based on both experimental analysis and theoretical modeling, providing a mechanistic understanding of how the antibiotic is broken apart step by step.

Reusability and practical potential

A catalyst that works brilliantly once but degrades after a single use has limited practical value. MBC-500 showed good stability through five cycles of reuse, with only moderate decline in performance. That durability is important for any real-world application, where the material would need to function continuously in a treatment system.

The use of biochar - which can be produced from agricultural waste, wood chips, or other biomass feedstocks - also addresses cost and sustainability concerns. Unlike some advanced nanomaterials that require expensive precursors, biochar is cheap and abundant.

From lab to treatment plant

The study demonstrates performance under controlled laboratory conditions with simulated sunlight and a single target antibiotic. Real wastewater contains complex mixtures of pollutants, varying pH levels, and dissolved organic matter that can compete for active sites on the catalyst. Scaling from benchtop to treatment plant involves engineering challenges - reactor design, flow rates, catalyst recovery - that this study does not address.

The work also focused on sulfadiazine specifically. Whether the same composite performs comparably against other antibiotic classes - fluoroquinolones, tetracyclines, macrolides - would need separate testing.

But as a proof of concept, the results are compelling: a low-cost, sunlight-driven material made partly from waste biomass that can destroy a common antibiotic pollutant at high efficiency and survive multiple use cycles. As antibiotic contamination of water resources continues to worsen worldwide, materials like this represent one piece of what will need to be a multi-pronged response.